Practical recommendations for the management of children with endemic Burkitt lymphoma (BL) in a resource limited

Peter Hesseling1, Trijn Israels, Mhamed Harif

  • 1Department of Paediatrics and Child Health, University of Stellenbosch, Cape Town, South Africa. pbh@sun.ac.za

Pediatric Blood & Cancer
|November 30, 2012
PubMed

Insights

Treatment guidelines for endemic Burkitt lymphoma (BL) in resource-limited settings are proposed. These recommendations aim to improve cure rates, which are typically below 50% for this pediatric cancer.

Area of Science:

  • Oncology
  • Pediatric Hematology-Oncology
  • Global Health

Background:

  • Endemic Burkitt lymphoma (BL) presents a significant challenge in low-resource settings, with cure rates often below 50% due to limited treatment capabilities.
  • Treatment protocols need adaptation for facilities with minimal requirements for curative care (PODC setting 1), where healthcare infrastructure varies considerably.

Purpose of the Study:

  • To develop evidence-based treatment recommendations for endemic Burkitt lymphoma (BL) tailored to resource-constrained environments.
  • To provide distinct therapeutic strategies addressing different clinical scenarios, including the inability to perform accurate staging and cases of relapse or poor response.

Main Methods:

  • A comprehensive literature review was conducted to gather existing data on BL treatment efficacy.
  • Personal clinical experience from managing BL in PODC setting 1 was integrated to refine treatment protocols.

Main Results:

  • Three distinct treatment schedules were formulated: one for non-staged disease, one for staged disease, and a rescue regimen for relapsed/refractory cases.
  • The 1-year event-free survival rates were recorded as 48% for treatment 1, 61% for treatment 2, and 35% for the rescue treatment.

Conclusions:

  • The proposed treatment recommendations offer a structured approach to managing endemic Burkitt lymphoma in settings with minimal curative care capabilities.
  • These guidelines aim to optimize outcomes and improve survival rates for children and adults with BL in resource-limited regions.